DACRESS Trademark

Trademark Overview


On Monday, August 19, 2019, a trademark application was filed for DACRESS with the United States Patent and Trademark Office. The USPTO has given the DACRESS trademark a serial number of 88584050. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 3, 2023. This trademark is owned by Pfizer Inc.. The DACRESS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use
dacress

General Information


Serial Number88584050
Word MarkDACRESS
Filing DateMonday, August 19, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 3, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 31, 2019

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 4, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Monday, April 3, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 3, 2023ABANDONMENT - NO USE STATEMENT FILED
Saturday, August 20, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 19, 2022SOU EXTENSION 5 GRANTED
Monday, August 8, 2022SOU EXTENSION 5 FILED
Tuesday, August 16, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 8, 2022TEAS EXTENSION RECEIVED
Thursday, January 20, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 18, 2022SOU EXTENSION 4 GRANTED
Tuesday, January 18, 2022SOU EXTENSION 4 FILED
Tuesday, January 18, 2022TEAS EXTENSION RECEIVED
Friday, July 23, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 21, 2021SOU EXTENSION 3 GRANTED
Wednesday, July 21, 2021SOU EXTENSION 3 FILED
Wednesday, July 21, 2021TEAS EXTENSION RECEIVED
Wednesday, February 3, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 1, 2021SOU EXTENSION 2 GRANTED
Monday, February 1, 2021SOU EXTENSION 2 FILED
Monday, February 1, 2021TEAS EXTENSION RECEIVED
Wednesday, August 5, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 3, 2020SOU EXTENSION 1 GRANTED
Monday, August 3, 2020SOU EXTENSION 1 FILED
Monday, August 3, 2020TEAS EXTENSION RECEIVED
Tuesday, February 25, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 31, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 31, 2019PUBLISHED FOR OPPOSITION
Wednesday, December 11, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 26, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 14, 2019ASSIGNED TO EXAMINER
Wednesday, September 4, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 22, 2019NEW APPLICATION ENTERED